BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11451447)

  • 21. Pituitary adenylate cyclase-activating polypeptide deficient mice show length abnormalities of the axon initial segment.
    Iwahashi M; Yoshimura T; Harigai W; Takuma K; Hashimoto H; Katayama T; Hayata-Takano A
    J Pharmacol Sci; 2023 Nov; 153(3):175-182. PubMed ID: 37770159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of PACAP administration on LPS-induced cytokine expression in the Atlantic salmon SHK-1 cell line.
    Campbell JH; Dang X; Rodríguez-Ramos T; Carpio Y; Estrada MP; Dixon B
    Fish Shellfish Immunol Rep; 2023 Dec; 5():100116. PubMed ID: 37753327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated Transcriptomic and Proteomic Study of the Mechanism of Action of the Novel Small-Molecule Positive Allosteric Modulator 1 in Targeting PAC1-R for the Treatment of D-Gal-Induced Aging Mice.
    Liang L; Chen S; Su W; Zhang H; Yu R
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PAC1 receptor (ADCYAP1R1) genotype is associated with dark-enhanced startle in children.
    Jovanovic T; Norrholm SD; Davis J; Mercer KB; Almli L; Nelson A; Cross D; Smith A; Ressler KJ; Bradley B
    Mol Psychiatry; 2013 Jul; 18(7):742-3. PubMed ID: 22776899
    [No Abstract]   [Full Text] [Related]  

  • 25. Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?
    Ashina M; Martelletti P
    J Headache Pain; 2018 May; 19(1):33. PubMed ID: 29740710
    [No Abstract]   [Full Text] [Related]  

  • 26. Calcitonin Receptor N-Glycosylation Enhances Peptide Hormone Affinity by Controlling Receptor Dynamics.
    Lee SM; Jeong Y; Simms J; Warner ML; Poyner DR; Chung KY; Pioszak AA
    J Mol Biol; 2020 Mar; 432(7):1996-2014. PubMed ID: 32035902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers.
    Niles LP; Armstrong KJ; Rincón Castro LM; Dao CV; Sharma R; McMillan CR; Doering LC; Kirkham DL
    BMC Neurosci; 2004 Oct; 5():41. PubMed ID: 15511288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pituitary adenylate cyclase-activating polypeptide].
    Gonzalez BJ; Basille M; Vaudry D; Fournier A; Vaudry H
    Ann Endocrinol (Paris); 1998 Dec; 59(5):364-405. PubMed ID: 9949891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors in the brain.
    Shioda S
    Kaibogaku Zasshi; 2000 Dec; 75(6):487-507. PubMed ID: 11197592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Photoaffinity labeling analysis of the interaction of pituitary adenylate-cyclase-activating polypeptide (PACAP) with the PACAP type I receptor.
    Cao YJ; Kojro E; Gimpl G; Jasionowski M; Kasprzykowski F; Lankiewicz L; Fahrenholz F
    Eur J Biochem; 1997 Mar; 244(2):400-6. PubMed ID: 9119005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A mutation in the second intracellular loop of the pituitary adenylate cyclase activating polypeptide type I receptor confers constitutive receptor activation.
    Cao YJ; Gimpl G; Fahrenholz F
    FEBS Lett; 2000 Mar; 469(2-3):142-6. PubMed ID: 10713259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel splice variants of type I pituitary adenylate cyclase-activating polypeptide receptor in frog exhibit altered adenylate cyclase stimulation and differential relative abundance.
    Alexandre D; Vaudry H; Grumolato L; Turquier V; Fournier A; Jégou S; Anouar Y
    Endocrinology; 2002 Jul; 143(7):2680-92. PubMed ID: 12072402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of binding domains of pituitary adenylate cyclase activating polypeptide (PACAP) for its type 1 receptor by photoaffinity labeling.
    Cao YJ; Kojro E; Jasionowski M; Lankiewicz L; Grzonka Z; Fahrenholz F
    Ann N Y Acad Sci; 1998 Dec; 865():82-91. PubMed ID: 9928000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
    Scaldaferri ML; Modesti A; Palumbo C; Ulisse S; Fabbri A; Piccione E; Frajese G; Moretti C
    Endocrinology; 2000 Mar; 141(3):1158-67. PubMed ID: 10698193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A constitutively active pituitary adenylate cyclase activating polypeptide (PACAP) type I receptor shows enhanced photoaffinity labeling of its highly glycosylated form.
    Cao Y; Gimpl G
    Biochim Biophys Acta; 2001 Jul; 1548(1):139-51. PubMed ID: 11451447
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.